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Purpose: Cerebral white matter lesions (WML) and brain atrophy are frequent in older persons 
and are associated with adverse outcomes. It has been suggested that aortic stiffness plays a role 
in the pathogenesis of WML and gray matter (GM) loss. There is, however, little evidence on 
the association between aortic stiffness and brain integrity in older patients. In this study, we 
investigated whether aortic stiffness is associated with WML and GM volume in older patients 
with cognitive and functional complaints.
Patients and methods: Fazekas score was used to analyze WML on brain imaging data of 
84 persons; in a subanalysis on 42 MRI scans, the exact volume of white matter hyperintensities 
(WMH) and GM was determined using a brain-tissue and WMH tool. Aortic stiffness, measured 
as aortic pulse wave velocity (aPWV) and central pulse pressure (cPP), and blood pressure levels 
were non-invasively measured by the Mobil-O-Graph.
Results: Mean age was 76.6 (±6.8) years. Age was correlated with cPP (Spearman’s ρ =0.296, 
P=0.008), aPWV (r²=0.785, P,0.001) and WMH volume (r²=0.297, P,0.001). cPP did not 
differ between categories of Fazekas, whereas aPWV increased with increasing Fazekas score 
(P for trend ,0.001). After additional adjustment for age, levels of aPWV did not differ between 
categories. Both cPP and aPWV were associated with WMH volumes (lnB 0.025, P=0.055 and 
lnB 0.405, P,0.001, respectively); after additional adjustment for age, estimates were less 
consistent. Both cPP and aPWV were negatively associated with GM volumes in multivariate 
analysis (B=2.805, P=0.094 and B=111.052, P=0.032).
Conclusion: Higher aortic stiffness was partly associated with increased volume of WMH 
and decreased volume of GM and slightly influenced by blood pressure. Age also plays a role 
in this association in older patients.
Keywords: vascular aging, white matter hyperintensities, gray matter, older persons, cognitive 
complaints, functional decline
Introduction
Cerebral white matter lesions (WML) and gray matter (GM) volume loss are frequently 
seen in older persons.1,2 These age-related processes can be associated not only with 
gait disturbances and mood disorder but also with cognitive and functional decline 
and mortality.3–8 Known risk factors for brain abnormalities are hypertension, diabetes 
mellitus, and inflammation.9–12 Also genetic predisposition, such as Anderson–Fabry 
disease, can result in WML.13,14 It has been suggested that arterial stiffness also plays 
a role in the pathogenesis of WML.15 Increased arterial stiffness leads to an increased 
pulsatile pressure, which can affect the microcirculation in high-flow organs leading 
to cerebral small vessel disease (CSVD).15,16 A recent systematic review and meta-
analysis was conducted on the association between arterial stiffness and CSVD.17 
Most studies included in the systematic review found an independent association 
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between arterial stiffness and different markers of CSVD.18–27 
However, most of these studies investigated the effect of arte-
rial stiffness on cerebral infarcts or cerebral microbleeds and 
not on WML.20–22,24,25,27 Several studies used brachial-ankle 
pulse wave velocity (PWV) instead of more reliable central 
measurements (ie, aortic stiffness) or included specific cat-
egories of patients at risk for cardiovascular disease.18,20–23,25,26 
There is, however, little evidence on the possible association 
between aortic stiffness and WML in the older patient. Also, 
little is known on the association between arterial stiffness 
and GM volume, which has only been investigated in young 
adults and selected groups of patients.28–31 No previous study 
has investigated the possible association between aortic 
stiffness and GM volume in older persons. The aim of this 
study was to investigate the relationship between measures 
of aortic stiffness and both GM volume and the severity of 
cerebral WML load in a population of elderly patients with 
cognitive and functional complaints.
Materials and methods
From April 2015 to June 2016, all patients entering the out-
patient clinic of geriatrics of the Erasmus MC, University 
Medical Center Rotterdam, were asked to participate in the 
study. Patients with (reliable) measurements of aortic stiff-
ness and brain imaging were included. MRI and computed 
tomography (CT) scans were used for analysis when brain 
imaging was performed within 6 months before or after the 
study visit. The ethical committee of the hospital approved 
this study and all participants signed informed consent. Dur-
ing the study visit, biographical information was collected 
and measurements of aortic stiffness were obtained. Medical 
history, medication, and lifestyle factors were documented. 
Height and weight were measured, and body mass index 
was calculated as kg/m². Global cognitive function was 
assessed with the Mini Mental State Examination score.32 
Katz index and Lawton and Brody index were used for scor-
ing activities of daily living (ADL) and instrumental ADL, 
respectively.33,34 Instrumental ADL dependency was defined 
as $1 limited activity.
Vascular measurements
Aortic stiffness was non-invasively measured with a 
validated method by the Mobil-O-Graph (Mobil-O-
Graph 24 hours PWA Monitor; I.E.M. GmbH, Stolberg, 
Germany).35,36 Central and peripheral systolic blood pressure 
(SBP), diastolic blood pressure (DBP), and pulse pressure 
(PP) were also measured. Aortic pulse wave velocity (aPWV) 
and central pulse pressure (cPP) were used to reflect aortic 
stiffness.35,37 Mean arterial pressure (MAP) was calculated 
as DBP +1/3 (SBP–DBP).
Brain imaging
Brain imaging was performed as part of clinical work-up 
of patients with cognitive and/or functional complaints. 
The Fazekas scale was used by one experienced radiolo-
gist to score the severity of WML on MRI and CT scans.38 
The Fazekas scale represents the sum of deep white matter 
corps and periventricular corps divided into three categories 
of increasing severity (0= absent, 1= punctuate foci, 
2= beginning confluence of foci, and 3= large confluent area). 
For more quantitative estimates, the brain tissue and white 
matter hyperintensity (WMH) segmentation tool, as devel-
oped by Quantib B.V. (www.quantib.com), was applied to 
T1-weighted and FLAIR scans. This tool generates automatic 
segmentations of GM, white matter (WM), cerebrospinal 
fluid and WMH in the cerebrum.39 The algorithm used is 
available for clinical use in the Quantib Brain product (v1.2) 
and an improved version is available in Quantib ND (v1.5). 
From these segmentations, we computed volumes in mil-
liliters of total GM and WMH.
statistical analyses
All analyses were performed using SPSS statistics 24. 
Descriptive data for continuous variables were presented 
as mean ± SD or median and IQR. Number and percent 
prevalences were presented for dichotomous variables. 
Data of variables with a skewed distribution (WMH in mm³ 
and cPP) were log-transformed using the natural logarithm. 
Spearman’s correlation analysis was used to investigate the 
relationship between age and cPP. Pearson’s correlation anal-
ysis was performed to investigate the relationship between 
age (independent variable) and aPWV, the natural logarithm 
of WMH volume, and GM volume (dependent variables). In 
analysis of covariance (ANCOVA), mean cPP and aPWV 
were investigated across categories of Fazekas score in three 
different models: model A was unadjusted; model B was 
adjusted for MAP; model C was adjusted for MAP and age. 
Mean values of cPP were back transformed to original scale. 
The significant associations in ANCOVA analysis were re-
evaluated using the Bonferroni method for multiple testing 
(P,0.0083). Linear regression analysis was performed to 
assess whether cPP and aPWV (determinant) were associ-
ated with WMH and GM volume, as a continuous variable 
(outcome). The same models as in the ANCOVA analyses 
were used. All tests were two-sided and a P-value ,0.05 was 
considered as statistically significant.
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Results
In total, 250 patients signed informed consent. A total of 
166 patients had no reliable measurements of aPWV and/or 
brain imaging available. Therefore, the study population 
consisted of 84 patients. The characteristics of the popula-
tion are shown in Table 1. Mean age was 76.6±6.8 years, 
65.5% were men, and 65.5% lived with a partner. Most of 
the patients were ADL independent (65.5%) and 26.2% were 
iADL independent.
Median peripheral SBP was 138.0 mmHg [IQR 
124.0–148.0] and DBP was 83.5 mmHg [IQR 77.0–93.0]. 
Median central SBP was 125.5 mmHg [IQR 114.3–136.0] 
and DBP was 85.0 mmHg [IQR 78.0–94.5]. Median cPP 
was 37.5 mmHg [IQR 31.0–45.8]. Mean aPWV was 
11.6±1.65 m/s. Fourteen percent of the patients were classi-
fied as Fazekas 0, 23.8% as Fazekas 1, 17.9% as Fazekas 2, 
and 44.0% as Fazekas 3. Median volume of WMH was 3.1 mL 
[IQR 0.8–6.4]. Mean GM volume was 679.5±130.7 mL.
Age was associated with cPP (Spearman’s ρ =0.296, 
P=0.008), aPWV (Pearson’s r=0.886, P,0.001), and WMH 
volume (Pearson’s r=0.545, P,0.001), but not with GM 
volume (Pearson’s r=-0.179, P=0.255). Results are shown 
in Figure 1.
Figure 2 shows the mean values and 95% CI of cPP 
and aPWV across Fazekas categories. No differences were 
found in mean cPP values across categories of Fazekas in 
unadjusted analysis (Figure 2A). Mean values and 95% CI 
were 35.3 (29.2–42.7) mmHg, 36.2 (31.2–41.9) mmHg, 
35.2 (29.7–41.7) mmHg, and 42.4 (37.8–47.5) mmHg from 
lowest to highest Fazekas categories, respectively. Mean 
values of cPP in model B slightly differed from univariate 
analysis (Figure 2B). Mean values and 95% CI were 
37.6 (31.4–44.9) mmHg, 36.3 (31.7–41.6) mmHg, 36.3 
(31.0–42.6) mmHg, and 40.7 (36.6–45.4) mmHg from lowest 
to highest Fazekas categories, respectively. In model C, 
no differences were found in mean values of cPP across 
categories of Fazekas (Figure 2C). Mean values and 95% 
CI were 39.5 (32.8–47.5) mmHg, 37.6 (32.7–43.2) mmHg, 
36.2 (31.0–42.3) mmHg, and 39.2 (35.0–44.0) mmHg from 
lowest to highest Fazekas categories, respectively.
Mean values of aPWV increased from lowest to highest 
categories of Fazekas (test for trend P,0.001) in unadjusted 
analysis (Figure 2D). Mean values and 95% CI were 10.4 
(9.6–11.2) m/s, 10.9 (10.3–11.5) m/s, 11.5 (10.7–12.2) 
m/s, and 12.6 (12.1–13.1) m/s, respectively. A significant 
difference in aPWV was found between categories 0 and 3 
(mean difference 2.2 m/s, P,0.001) and 1 and 3 (mean 
difference 1.7 m/s, P,0.001). In model B, aPWV was 
higher in those in Fazekas 3 than those in Fazekas 0 (mean 
difference 1.8 m/s, P,0.001) and in Fazekas 1 (mean dif-
ference 1.5 m/s, P,0.001). Furthermore, aPWV increased 
from lowest to highest categories of Fazekas (test for trend 
P,0.001) comparable with unadjusted analysis (Figure 2E). 
Mean values and 95% CI of aPWV from lowest to highest 
categories were 10.7 (9.9–11.4) m/s, 10.9 (10.3–11.5) m/s, 
11.6 (10.9–12.3) m/s, and 12.4 (12.0–12.9) m/s, respectively. 
In model C, aPWV did no longer differ between categories 
of Fazekas. Mean values and 95% CI of aPWV were 11.7 
(11.4–11.9) m/s, 11.6 (11.4–11.8) m/s, 11.5 (11.3–11.7) m/s, 
and 11.7 (11.5–11.8) m/s from lowest to highest Fazekas 
categories, respectively (Figure 2F).
Levels of cPP showed a trend toward linear associa-
tion with (natural logarithm of) WMH (lnB =0.025, 95% 
CI -0.001; 0.052) and this trend only slightly changed in 
model B (lnB =0.027, 95% CI -0.001; 0.056). Nonetheless, 
in model C, no association was found between cPP and WMH 
(lnB =0.014, 95% CI -0.013; 0.040) (Table 2). Levels of 
aPWV were linearly associated with (natural logarithm of) 
Table 1 Characteristics of the study population (n=84)
Age in years, mean (±sD)
Men, n (%)
living alone, n (%)
living with partner, n (%)
Current smoker, n (%)
ex-smoker, n (%)
ADl independent, n (%)
iADl independent, n (%) 
MMse score, median [IQr] 
history of hypertension, n (%)
history of diabetes mellitus, n (%)
Peripheral hemodynamics
psBP in mmhg, median [IQr] 
pDBP in mmhg, median [IQr] 
pPP in mmhg, median [IQr] 
Central hemodynamics
csBP in mmhg, median [IQr]
cDBP in mmhg, median [IQr]
cPP in mmhg, median [IQr]
aPWV in m/s, mean (±sD)
Brain integrity
Fazekas category 0, n (%)
Fazekas category 1, n (%)
Fazekas category 2, n (%)
Fazekas category 3, n (%)
WMh in ml, median [IQr]a 
gray matter in ml, mean (±sD)a
76.4 (±7.0)
55 (65.5)
29 (34.5)
55 (65.5)
11 (13.1)
44 (52.4)
55 (65.5)
22 (26.2)
25.5 [23–28]
37 (44.0)
24 (28.6)
138.0 [124.0–148.0]
83.5 [77.0–93.0]
50.0 [42.5–63.8] 
125.5 [114.3–136.0]
85.0 [78.0–94.5]
37.5 [31.0–45.8]
11.6 (±1.65)
12 (14.3)
20 (23.8)
15 (17.9)
37 (44.0)
3.1 [0.8–6.4]
679.5 (±130.7)
Note: aData on WMh and gray matter were available for 42 patients.
Abbreviations: ADl, activities of daily living; iADl, instrumental activities of daily 
living; psBP, peripheral systolic blood pressure; pDBP, peripheral diastolic blood 
pressure; pPP, peripheral pulse pressure; csBP, central systolic blood pressure; 
cDBP, central diastolic blood pressure; cPP, central pulse pressure; aPWV, aortic 
pulse wave velocity; WMh, white matter hyperintensity.
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Figure 1 Association between age and measures of aortic stiffness and brain integrity.
Notes: (A) Central pulse pressure (cPP); (B) aortic pulse wave velocity (aPWV); (C) natural logarithm of white matter hyperintensities (log-WMh); and (D) gray matter (gM).
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Figure 2 Mean values of aortic stiffness across categories of Fazekas scores.
Notes: (A–C) Central pulse pressure (cPP); (D–F) aortic pulse wave velocity (aPWV). Model A, unadjusted; model B, adjusted for mean arterial pressure; model C, adjusted 
for mean arterial pressure and age. P-value ,0.05/6 is statistically significant (Bonferroni correction). Dots represent mean values and bars represent 95% CI.
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WMH (lnB =0.405, 95% CI 0.204; 0.606) and remained 
significant in model B (lnB =0.449, 95% CI 0.233; 0.664). 
In model C, however, no association was found between 
aPWV and WMH (lnB =0.382, 95% CI -0.436; 1.201).
Levels of cPP were negatively associated with GM volume 
in univariate analysis (B=-2.952, 95% CI -5.818; -0.086). 
In models B and C, a negative trend toward association was 
found between cPP and WMH (B=-3.080, 95% CI -6.207; 
0.046; B=-2.805, 95% CI -6.111; 0.501, respectively). 
A negative trend was also found between aPWV and GM 
volume in univariate analysis (B=-22.235, 95% CI -47.653; 
3.183). In model B, estimates were slightly less consistent 
(B=-22.766, 95% CI -50.495; 4.963). In model C, a nega-
tive association was found between aPWV and GM volume 
(B=-111.052, 95% CI -211.840; -10.265).
Discussion
In this study, we found that higher aortic stiffness was partly 
associated with a higher load of cerebral WML and lower 
GM volume in patients with cognitive and functional com-
plaints. This association was slightly influenced by blood 
pressure. Higher aortic stiffness was found to be associated 
with a higher Fazekas score. The association was strongly 
mediated by age.
In a community-based cohort of 668 participants who 
were between the age of 69 and 93, higher levels of carotid-
femoral pulse wave velocity were associated with diffuse 
microvascular brain lesions, which included subcortical 
infarcts and higher volumes of WMH.24 Carotid pulse pres-
sure was associated with increased risk of silent subcortical 
infarcts. However, this study was performed in an apparently 
healthy population of older individuals, and those with a his-
tory of stroke, transient ischemic attack, or dementia were 
excluded. Considering these differences in the inclusion, the 
results of the two studies are not completely comparable. 
Also, previous studies were most often performed in spe-
cific categories of patients such as young hypertensives and 
diabetics.18,23 In these populations, higher aortic stiffness was 
associated with a greater volume of WMH. In addition, Saji 
et al found that increased brachial-ankle PWV was associated 
with WML in healthy adults in Japan.40 Since brachial-ankle 
PWV is not a measure of aortic stiffness, these results could 
not be compared with our findings. A recent systematic 
review made an overview of all studies investigating the 
association between arterial stiffness and CSVD, summing 
up the results in diverse study populations using diverse 
methods of defining arterial stiffness and CSVD.17 Out of the 
15 cross-sectional studies included, 73% showed an associa-
tion between greater arterial stiffness and CSVD.17
A few studies found an inverse relation between aortic 
stiffness and GM volume.28–30 However, these studies were 
conducted in young and healthy adults, in type 2 diabetics, 
and in patients with manifest arterial disease. No previous 
study has investigated the potential role of aortic stiffness in 
determining brain integrity in older persons with cognitive 
and functional complaints.
 The mechanisms underlying the association between 
aortic stiffness and CSVD have previously been described 
as when aortic stiffness increases the pulsatile pressure.15,16 
High pulsatile pressure increases the flow load and can cause 
damage in high-flow organs. This damage can be seen as 
WML, but also as cerebral microbleeds and lacunar infarcts, 
which are all markers of CSVD. The high pressure can affect 
the brain directly resulting in microvascular damage. Besides 
the direct damage that increased flow load can cause, it may 
also induce an indirect remodeling response by elevating 
the vascular resistance to protect the microvascular system 
from high pressures. This response might lead to ischemia 
in the long term.17 Moreover, GM atrophy may be the result 
of damages to the small cerebral arteries caused by vascular 
disease in advanced stage.28 The role of age in vascular pro-
cesses is attributed to degenerative changes. At a molecular 
level, vascular aging is characterized by breaks in elastin 
fibers, accumulation of collagen, fibrosis, inflammation, 
Table 2 Linear regression coefficients describing the associations between measures of aortic stiffness and brain integrity (n=42)
White matter hyperintensity  
volume in mm³ 
lnB (95% CI)
Gray matter volume in mL
B (95% CI)
Central pulse pressure (mmHg)
Model A
Model B
Model C
0.025 (-0.001; 0.052)
0.027 (-0.001; 0.056)
0.014 (-0.013; 0.040)
-2.952 (-5.818; -0.086)
-3.080 (-6.207; 0.046)
-2.805 (-6.111; 0.501)
Aortic pulse wave velocity (m/s)
Model A
Model B
Model C
0.405 (0.204; 0.606)
0.449 (0.233; 0.664)
0.382 (-0.436; 1.201)
-22.235 (-47.653; 3.183)
-22.766 (-50.495; 4.963)
-111.052 (-211.840; -10.265)
Notes: Model A, unadjusted; model B, adjusted for mean arterial pressure; model C, adjusted for mean arterial pressure and age.
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and calcifications. All these processes result in a decline 
of the elastic properties of the central large arteries.41 Also 
cardiovascular diseases contribute to the decline of these 
elastic properties due to vascular remodeling.9 Interestingly, 
in this study population, the majority have had or still had 
cardiovascular diseases. However, the role of age still seems 
to be very important. We cannot exclude that associations 
between aortic stiffness and brain integrity would be different 
in a study population with a wider range of age and there-
fore a different time of exposure to risk factors. Moreover, 
we are aware that participants of the present study have an 
elevated load of degenerative vascular alterations due to 
age and comorbidities and possibly patients with elevated 
vascular stiffness might not be included in the study due to 
morbidity or mortality.
This study has some limitations. First, the cross-sec-
tional study design did not allow us to draw conclusions 
about causality. Second, the low number of available MRI 
scans can limit the possibility to add further adjustments 
in analysis on WMH and GM. Third, we included older 
patients within a relatively small range of age and with an 
elevated load of degenerative vascular alterations. These 
“ceiling effects” in a relatively small sample of elderly 
could limit the ability to assess the role of aortic stiffness 
in brain integrity. 
This study also has strengths. First, we used both graded 
scores (Fazekas) and more quantitative and automatic 
methods for assessing the cerebral WML load in order to 
investigate the association between aortic stiffness and 
WML. Moreover, the Fazekas score was scored by one expe-
rienced radiologist, which makes the results less susceptible 
to variability as a result of different raters. Second, we used 
two parameters of central arterial stiffness. cPP and aPWV 
both reflect aortic stiffness.35,37 Aortic stiffness is known to 
play a fundamental role in the development and progression 
of disease in end organs.42 Thus, the use of aortic stiffness 
as a parameter to assess brain integrity makes the outcomes 
of this study clinically relevant.
Conclusion
We found that higher levels of aortic stiffness were partly 
associated with increased cerebral WML load and decreased 
GM volume in elderly patients with cognitive and func-
tional complaints. This association seems to be slightly 
influenced by blood pressure and strongly driven by age. 
In this population of older patients, majority of whom were 
exposed to cardiovascular disease, age is still an important 
factor, most likely due to a cumulative exposure to risk 
factors and age-related degenerative processes. Prospective 
investigations in a larger geriatric population are recom-
mended to investigate the independent role of aortic stiff-
ness in the development and progression of WML and loss 
of GM over time.
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